SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
76.80
Ask:
77.80
Spread: 1.00 (1.302%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Director/PDMR Shareholding

30 Jun 2025 12:30

RNS Number : 0073P
Accsys Technologies PLC
30 June 2025
 

Accsys Technologies PLC (the "Company")

Director/PDMR Grant of Share Awards under the Accsys Deferred Bonus Plan and under the Accsys Long Term Incentive Plan and Issue of Shares

The Company announces that following recommendation from its Remuneration Committee, on 27 June 2025 (the "Grant Date") it granted awards over 2,248,645 ordinary shares of €0.05 each in the Company ("Shares") under its Deferred Bonus Plan ("DBP") and granted nil cost options over 1,883,769 Shares under its 2025 Long Term Incentive Plan ("LTIP") to certain employees and the Company's Executive Directors, Jelena Arsic van Os and Sameet Vohra, as further set out below.

Deferred Bonus Plan

Awards under the DBP have been granted in respect of bonuses earned for the financial year ending 31 March 2025 over a total of 2,248,645 Shares (the "Bonus Shares"), including to the Executive Directors in such numbers as set out below. The awards to Executive Directors vest 80% on the Grant Date and 20% on the second anniversary of the Grant Date, subject in each case to the sale of such number of Bonus Shares as is required to cover each Director's respective tax and social security liabilities.

Director

Role

Number of Bonus Shares awarded

Number of Bonus Shares vesting on Grant Date

Number of Bonus Shares vesting on second anniversary of Grant Date

Jelena Arsic van Os

Chief Executive Officer

526,435

421,148

105,287

Sameet Vohra

Chief Financial Officer

178,853

143,082

35,771

 

Long Term Incentive Plan 2025 Awards

Awards of nil cost options under the LTIP have been granted over a total of 1,883,769 Shares to various senior employees, including to the Executive Directors in such numbers as are set out below, in accordance with the terms of the LTIP Rules.

The nil cost options are expected to vest three years after grant, subject to the terms of the LTIP Rules, including continued employment of the beneficiaries by the Company and satisfaction of financial and non-financial performance conditions. Details of the performance conditions will be included in the FY26 Annual Report. A two-year holding period applies following the end of the performance period for Executive Directors only.

 

 

 

Director

Role

Number of nil cost options over Ordinary Shares awarded

Jelena Arsic van Os

Chief Executive Officer

778,693

Sameet Vohra

Chief Financial Officer

425,432

 

Following the awards made under the DBP, Jelena Arsic van Os is now beneficially interested in 509,398 Shares and Sameet Vohra is now beneficially interested in 143,082 Shares.

New Share Issues

 

In satisfaction of the grant of awards under the DBP as announced above, the Company further announces the issue of 2,248,645 Bonus Shares to the Company's Employee Benefit Trust ("EBT"), the beneficiaries of which include employees and the Executive Directors.

Application for admission of the Bonus Shares to trading on AIM and Euronext Amsterdam has now been made, with admission expected on or around 3 July 2025. The Company does not hold any shares in treasury. Therefore, the total voting rights in the Company following the issue of the Bonus Shares will be 242,694,212. Following the issue of the Bonus Shares, this figure may be used by shareholders as the denominator for the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company's securities under the FCA's Disclosure Guidance and Transparency Rules.

The Company shall make a further announcement once the sale of Shares, as is required to cover each Executive Director's respective tax and social security liabilities, has been completed in respect of the awards vesting on the Grant Date.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jelena Arsic van Os

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Accsys Technologies plc

b)

LEI

213800HKRFK8PNUNV581

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.05 each

b)

Identification code

ISIN:  GB00BQQFX454

c)

Nature of the transaction

Transaction 1

Award of Bonus Shares under the Accsys Deferred Bonus Plan

Transaction 2

LTIP 2025 award of nil cost options

d)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) Award of Bonus Shares

Nil

526,435

2) LTIP 2025 award of nil cost options

Nil

778,693

e)

Aggregated information

Volume

Price

N/A

f)

Date of the transaction

27 June 2025

g)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Sameet Vohra

2.

Reason for the notification

 

 

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Accsys Technologies plc

b)

LEI

213800HKRFK8PNUNV581

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.05 each

b)

Identification code

ISIN:  GB00BQQFX454

c)

Nature of the transaction

Transaction 1

Award of Bonus Shares under the Accsys Deferred Bonus Plan

Transaction 2

LTIP 2025 award of nil cost options

d)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

Award of Bonus Shares

Nil

178,853

LTIP 2025 award of nil cost options

Nil

425,432

e)

Aggregated information

Volume

Price

N/A

f)

Date of the transaction

27 June 2025

g)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFBLFXEQLFBBF
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
2nd Sep 20245:00 pmRNSTotal Voting Rights
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.